Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Tan, Jing Chen, J. Digby, S. Keay, C. Kennedy, Harpal Endocrinology, Metabolism Group (2006)
Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin.The Journal of clinical endocrinology and metabolism, 91 12
W. Jian, T. Luo, Yanyun Gu, Hong-li Zhang, Sheng Zheng, M. Dai, Jin Han, Yu Zhao, Guo Li, Min Luo (2006)
The visfatin gene is associated with glucose and lipid metabolism in a Chinese populationDiabetic Medicine, 23
(2006)
Adipose tissue: from lipid storage compartment to endocrine organ, 55
Ching-Chu Chen, Tsai-Chung Li, Chia-Ing Li, C. Liu, Wen-Yuan Lin, Ming-Tsang Wu, M. Lai, Cheng-Chieh Lin (2007)
The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women.Metabolism: clinical and experimental, 56 9
M. Ozkaya, E. Çakal, Y. Ustun, Y. Engin-Ustun (2010)
Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.Fertility and sterility, 93 3
R. MacLaren, W. Cui, W. Cui, K. Cianflone, K. Cianflone (2007)
Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3‐L1 pre‐adipocytes and adipocytesDiabetes, 9
E. Diamanti-Kandarakis (2006)
Insulin resistance in PCOSEndocrine, 30
E. Aigner, Nora Bachofner, K. Klein, C. Geyter, F. Hohla, W. Patsch, C. Datz (2009)
Retinol-binding protein 4 in polycystic ovary syndrome--association with steroid hormones and response to pioglitazone treatment.The Journal of clinical endocrinology and metabolism, 94 4
I. Kowalska, M. Strączkowski, A. Nikołajuk, A. Adamska, M. Karczewska-Kupczewska, E. Otziomek, S. Wołczyński, M. Górska (2007)
Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.Human reproduction, 22 7
C. Pagano, C. Pilon, M. Olivieri, Paola Mason, R. Fabris, R. Serra, G. Milan, M. Rossato, G. Federspil, R. Vettor (2006)
Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans.The Journal of clinical endocrinology and metabolism, 91 8
Emre Dikmen, I. Tarkun, Z. Cantürk, B. Çetinarslan (2011)
Plasma visfatin level in women with polycystic ovary syndromeGynecological Endocrinology, 27
T. Doğru, A. Sonmez, I. Tasci, E. Bozoglu, M. Yılmaz, H. Genç, G. Erdem, M. Gok, N. Bingol, S. Kılıç, T. Ozgurtas, S. Bingol (2007)
Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.Diabetes research and clinical practice, 76 1
A. Fukuhara, M. Matsuda, M. Nishizawa, Katsumori Segawa, Masaki Tanaka, Kae Kishimoto, Yasushi Matsuki, M. Murakami, T. Ichisaka, H. Murakami, Eijiro Watanabe, T. Takagi, M. Akiyoshi, Tsuguteru Ohtsubo, S. Kihara, S. Yamashita, M. Makishima, T. Funahashi, S. Yamanaka, R. Hiramatsu, Y. Matsuzawa, I. Shimomura (2005)
Visfatin: a protein secreted by visceral fat that mimics the effects of insulin.Science, 307 5708
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(4):1929–1935 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1045 Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycysti
K. Berneis, M. Rizzo, M. Hersberger, G. Rini, G. Fede, I. Pepe, G. Spinas, E. Carmina (2009)
Atherogenic forms of dyslipidaemia in women with polycystic ovary syndromeInternational Journal of Clinical Practice, 63
B. Fauser (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Human reproduction, 19 1
C. Curat, V. Wegner, C. Sengenès, A. Miranville, C. Tonus, R. Busse, A. Bouloumié (2006)
Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatinDiabetologia, 49
Blake Gj, P. Ridker (2002)
Inflammatory bio‐markers and cardiovascular risk predictionJournal of Internal Medicine, 252
A. Dunaif (1997)
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.Endocrine reviews, 18 6
M. Asunción, R. Calvo, J. Millán, J. Sancho, S. Avila, H. Escobar-Morreale (1999)
The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain*
D. Panidis, D. Farmakiotis, D. Rousso, I. Katsikis, D. Delkos, A. Piouka, S. Gerou, E. Diamanti-Kandarakis (2008)
Plasma visfatin levels in normal weight women with polycystic ovary syndrome.European journal of internal medicine, 19 6
A. Onat, G. Hergenç, H. Özhan, Z. Kaya, S. Bulur, E. Ayhan, G. Can (2008)
Lipoprotein(a) is associated with coronary heart disease independent of metabolic syndromeCoronary Artery Disease, 19
D. Haider, K. Schindler, G. Schaller, G. Prager, M. Wolzt, B. Ludvik (2006)
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding.The Journal of clinical endocrinology and metabolism, 91 4
M. Möhlig, J. Spranger, M. Osterhoff, M. Ristow, A. Pfeiffer, T. Schill, H. Schlösser, G. Brabant, C. Schöfl (2004)
The polycystic ovary syndrome per se is not associated with increased chronic inflammation.European journal of endocrinology, 150 4
I. Tarkun, Emre Dikmen, B. Çetinarslan, Z. Cantürk (2010)
Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome.European cytokine network, 21 4
(2005)
Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome, 90
J. Berndt, N. Klöting, S. Kralisch, P. Kovacs, M. Fasshauer, M. Schön, M. Stumvoll, M. Blüher (2005)
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.Diabetes, 54 10
R. Lobo, E. Carmina (2000)
The Importance of Diagnosing the Polycystic Ovary SyndromeAnnals of Internal Medicine, 132
A. Kaminska, E. Kopczynska, A. Bronisz, M. Żmudzińska, M. Bieliński, A. Borkowska, T. Tyrakowski, R. Junik (2010)
An evaluation of visfatin levels in obese subjects.Endokrynologia Polska, 61 2
B. Samal, Ying Sun, G. Stearns, Chunshan Xie, S. Suggs, I. Mcniece (1994)
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factorMolecular and Cellular Biology, 14
(1995)
Polycystic ovary syndrome, 333
C. Ersoy, Ganime Sadikoglu, Hasan Orhan, M. Guclu, E. Sarandol, Meral Akgun, Alis Ozcakir, Ş. Imamoğlu (2010)
Body fat distribution has no effect on serum visfatin levels in healthy female subjects.Cytokine, 49 3
T. Jongwutiwes, S. Lertvikool, S. Leelaphiwat, S. Rattanasiri, Rattiya Jultanmas, S. Weerakiet (2009)
Serum visfatin in Asian women with polycystic ovary syndromeGynecological Endocrinology, 25
B. Yıldız, G. Bozdag, U. Otegen, Ayla Harmanci, K. Boynukalin, Z. Vural, Ş. Kirazlı, H. Yarali (2010)
Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS.Reproductive biomedicine online, 20 1
D. Ehrmann, R. Barnes, R. Rosenfield, M. Cavaghan, J. Imperial (1999)
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.Diabetes care, 22 1
T. Filippatos, C. Derdemezis, I. Gazi, K. Lagos, D. Kiortsis, A. Tselepis, M. Elisaf (2007)
Increased plasma visfatin levels in subjects with the metabolic syndromeEuropean Journal of Clinical Investigation, 38
(2000)
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain, 85
C. Glueck, Ranganath Papanna, Ping Wang, N. Goldenberg, L. Sieve-Smith (2003)
Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.Metabolism: clinical and experimental, 52 7
R. Gen, E. Akbay, N. Muşlu, K. Sezer, F. Çayan (2009)
Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistanceGynecological Endocrinology, 25
A. Dunaif, K. Segal, W. Futterweit, A. Dobrjansky (1989)
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary SyndromeDiabetes, 38
Jung-ha Kim, Sang-Hwan Kim, J. Im, Duk-Chul Lee (2010)
The relationship between visfatin and metabolic syndrome in postmenopausal women.Maturitas, 67 1
The aim of this study is to determine the serum levels of visfatin in patients with polycystic ovary syndrome (PCOS) and to understand its correlations with other metabolic and hormonal parameters. Thirty-seven patients with PCOS and 30 women without concomitant disease were included in this study. Serum visfatin levels were similar in patients with PCOS and control group. Visfatin levels were higher in normal weight PCOS when compared with obese PCOS, but it did not reach statistical significance. Visfatin levels correlated negatively with fasting blood glucose, total cholesterol (TC), low-density lipoprotein (LDL) and lipoprotein-a levels in PCOS patients. CRP levels increased both in obese PCOS and in obese controls. Plasma visfatin levels had no correlation with homeostasis model assessment-insulin resistance and fasting insulin levels, but the negative correlation between plasma visfatin levels and lipoprotein-a, fasting plasma glucose, TC and LDL levels may indicate a role for visfatin in cardiovascular disease independent of insulin resistance.
Gynecological Endocrinology – Taylor & Francis
Published: Aug 1, 2012
Keywords: CRP; lipoprotein-a; obesity; polycystic ovary syndrome; visfatin
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.